Further investigation on the effects of IFN-β treatment of MS found that IFN-β also prevented the migration of dendritic cell from inflammatory regions to draining lymph nodes for antigen presentation and activation of naive T cells. Here, IFNB1 is linked to myeloid sarcoma.